-
Cabozantinib, sold
under the
brand names Cometriq and
Cabometyx among others, is an anti-cancer
medication used to
treat medullary thyroid cancer, renal...
-
partnered its lead
cancer drug candidate, XL-184 (which
would become called cabozantinib) and
another cancer candidate, XL-281, with
Bristol Myers Squibb; BMS...
- surgery.
Cabozantinib,
trade name Cometriq, was
granted marketing approval (November 2012) by the U.S. FDA for this indication.
Cabozantinib which is...
- daclatasvir, sofosbuvir, afatinib, axitinib, brigatinib, baricitinib,
cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib, lenvatinib, palbociclib...
- that it is due to the
decreased absorption of
abacavir by orlistat.
Cabozantinib:
Drugs from the MRP2
inhibitor (Multidrug resistance-****ociated protein...
-
common adverse reaction to
cytotoxic chemotherapy drugs,
particularly cabozantinib, cytarabine, doxorubicin, and
fluorouracil and its
prodrug capecitabine...
-
cabergoline (INN)
cabiotraxetan (INN)
Cablivi Cabometyx cabotegravir cabozantinib (USAN, INN)
Cabtreo cactinomycin (INN)
cadazolid (INN)
cadexomer (INN)...
- (PNB-0408)
Kinase inhibitors:
Altiratinib AM7 AMG-458
Amuvatinib BMS-777607
Cabozantinib Capmatinib Crizotinib Foretinib Golvatinib INCB28060 JNJ-38877605 K252a...
- cell
carcinoma over
everolimus in 2015 and was
approved by the FDA.
Cabozantinib also
demonstrated an
overall survival benefit over
everolimus and was...
- (PNB-0408)
Kinase inhibitors:
Altiratinib AM7 AMG-458
Amuvatinib BMS-777607
Cabozantinib Capmatinib Crizotinib Foretinib Golvatinib INCB28060 JNJ-38877605 K252a...
